Yung-Mae Yao

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 553 citations

PTEN-deficient cancers depend on PIK3CB

Susan Wee, Dmitri Wiederschain, Sauveur-Michel Maira et al. · Proceedings of the National Academy of Sciences · 2008 · 546 citations · Full text

Tumor Biology, Class Ia Pi3k, Signal Transduction +15

Single-vector inducible lentiviral RNAi system for oncology target validation

Dmitri Wiederschain, W Nicolson Susan, Lin Chen et al. · Cell Cycle · 2009 · 453 citations · Full text

Engineering, Oncology Target Validation, Cancer Biology +16

The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells

Zainab Jagani, Dmitri Wiederschain, Alice Loo et al. · Cancer Research · 2010 · 66 citations

Hematological Malignancy, Cancer Research, Bim Knockdown +14

Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <i>BRAF</i> or <i>KRAS</i> Mutations

Yung-Mae Yao, Gregory P. Donoho, Philip W. Iversen et al. · Clinical Cancer Research · 2017 · 45 citations · Full text